The CB1 receptor antagonist rimonabant controls cell viability and ascitic tumour growth in mice

Pharmacological Research

Volumn 65, Issue 3, 2012, Pages 365-371

  Malfitano, Anna Maria ^a   Laezza, Chiara ^b   Galgani, Mario ^b   Matarese, Giuseppe ^b   D'Alessandro, Alba ^a   Gazzerro, Patrizia ^a   Bifulco, Maurizio ^a  

^a UNIVERSITY OF SALERNO   (Italy)

^b CNR   (Italy)

Author keywords

Animal model; Anti tumour effect; Ascites; CB1 antagonist

Indexed keywords

3 METHYLCHOLANTHRENE; CANNABINOID 1 RECEPTOR; CYCLIN D1; CYCLIN E; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE B; RIMONABANT; TRANSCRIPTION FACTOR FKHR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; ASCITES TUMOR; CANCER INHIBITION; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFICACY; FEMALE; FIBROSARCOMA; FLOW CYTOMETRY; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TREATMENT RESPONSE; TUMOR CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; ASCITES; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; FEMALE; FIBROSARCOMA; GENE EXPRESSION REGULATION, NEOPLASTIC; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PIPERIDINES; PYRAZOLES; RECEPTOR, CANNABINOID, CB1; SARCOMA;

EID: 84857063038     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2011.11.008     Document Type: Article

References (46)

1. M. Rinaldi-Carmona, F. Barth, M. Héaulme, R. Alonso, D. Shire, and C. Congy Biochemical and pharmacological characterisation of SR 141716A, the first potent and selective brain cannabinoid receptor antagonist Life Sci 56 1995 1941 1947
2. M. Rinaldi-Carmona, F. Barth, M. Héaulme, D. Shire, B. Calandra, and C. Congy SR141716A, a potent and selective antagonist of the brain cannabinoid receptor FEBS Lett 350 1994 240 244 (Pubitemid 24268029)
3. G. Colombo, R. Agabio, G. Diaz, C. Lobina, R. Reali, and G.L. Gessa Appetite suppression and weight loss after the cannabinoid antagonist SR 141716 Life Sci 63 1998 PL113 PL117
4. C. Ravinet Trillou, M. Arnone, C. Delgorge, N. Gonalons, P. Keane, and J.P. Maffrand Anti-obesity effect of SR 141716, a CB1 receptor antagonist, in diet-induced obese mice Am J Physiol Regul Integr Comp Physiol 284 2003 R345 R353
5. M.A. Carai, G. Colombo, and G.L. Gessa Rimonabant: the first therapeutically relevant cannabinoid antagonist Life Sci 77 2005 2339 2350 (Pubitemid 41206861)
6. O. Jbilo, C. Ravinet-Trillou, M. Arnone, I. Buisson, E. Bribes, and A. Peleraux The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance FASEB J 19 2005 1567 1569 (Pubitemid 41279033)
7. V. Di Marzo, and I. Matias Endocannabinoid control of food intake and energy balance Nat Neurosci 8 2005 585 589 (Pubitemid 40594198)
8. S. Engeli, J. Bohnke, M. Feldpausch, K. Gorzelniak, J. Janke, and S. Batkai Activation of the peripheral endocannabinoid system in human obesity Diabetes 54 2005 2838 2843 (Pubitemid 41401077)
9. V. Di Marzo The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation Pharmacol Res 60 2 2009 77 84
10. M. Bifulco, C. Laezza, M. Valenti, A. Ligresti, G. Portella, and V. Di Marzo A new strategy to block tumor growth by inhibiting endocannabinoid inactivation FASEB J 18 2004 1606 1608 (Pubitemid 39561648)
11. C. Grimaldi, S. Pisanti, C. Laezza, A.M. Malfitano, A. Santoro, and M. Vitale Anandamide inhibits adhesion and migration of breast cancer cells Exp Cell Res 312 2006 363 373 (Pubitemid 41804104)
12. M. Bouaboula, M. Rinaldi, O. Carayon, C. Carillon, B. Delpech, and D. Shire Cannabinoid-receptor expression in human leukocytes Eur J Biochem 214 1993 173 180 (Pubitemid 23168532)
13. D.P. Hurst, D.L. Lynch, J. Barnett-Norris, S.M. Hyatt, H.H. Seltzman, and M. Zhong N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl- 1Hpyrazole-3-carboxamide (SR141716A) interaction with LYS 3.28(192) is crucial for its inverse agonism at the cannabinoid CB1 receptor Mol Pharmacol 62 2002 1274 1287 (Pubitemid 35403823)
14. J. Flygare, K. Gustafsson, E. Kimby, B. Christensson, and B. Sander Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma FEBS Lett 579 2005 6885 6889 (Pubitemid 41773704)
15. M. Maccarrone, T. Lorenzon, M. Bari, G. Melino, and A. Finazzi-Agro Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors J Biol Chem 275 2000 31938 31945
16. S.O. Jacobsson, T. Wallin, and C.J. Fowler Inhibition of rat C6 glioma cell proliferation by endogenous and synthetic cannabinoids. Relative involvement of cannabinoid and vanilloid receptors J Pharmacol Exp Ther 299 2001 951 959 (Pubitemid 33104965)
17. D. Sarnataro, S. Pisanti, A. Santoro, P. Gazzerro, A.M. Malfitano, and C. Laezza The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid rafts mediated mechanism Mol Pharmacol 70 2006 1298 1306 (Pubitemid 44435982)
18. A.M. Malfitano, C. Laezza, S. Pisanti, P. Gazzerro, M. Bifulco, and Rimonabant (SR141716) exerts anti-proliferative and immunomodulatory effects in human peripheral blood mononuclear cells Br J Pharmacol 153 2007 1003 1010
19. A. Santoro, P. Gazzerro, A.M. Malfitano, S. Pisanti, C. Laezza, and M. Bifulco Reply to the letter to the editor "Long-term cannabinoid receptor (CB1) blockade in obesity: implications for the development of colorectal cancer" Int J Cancer 123 2008 243 244 (Pubitemid 351705217)
20. A. Santoro, S. Pisanti, C. Grimaldi, A. Izzo, F. Borrelli, and M.C. Proto Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon Int J Cancer 125 2009 996 1003
21. P. Gazzerro, A.M. Malfitano, M.C. Proto, A. Santoro, S. Pisanti, and M.G. Caruso Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin Oncol Rep 23 1 2010 171 175
22. P. Mukhopadhyay, H. Pan, M. Rajesh, S. Bátkai, V. Patel, and J. Harvey-White CB1 cannabinoid receptors promote oxidative/nitrosative stress: inflammation and cell death in a murine nephropathy model Br J Pharmacol 160 3 2010 657 668
23. P. Mukhopadhyay, M. Rajesh, S. Bátkai, V. Patel, Y. Kashiwaya, and L. Liaudet CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes Cardiovasc Res 85 4 2010 773 784
24. P. Mukhopadhyay, B. Horváth, M. Rajesh, S. Matsumoto, K. Saito, and S. Bátkai Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injury Free Radic Biol Med 50 1 2011 179 195
25. P. Mukhopadhyay, S. Bátkai, M. Rajesh, N. Czifra, J. Harvey-White, and G. Haskó Pharmacological inhibition of CB1 cannabinoid receptor protects against doxorubicin-induced cardiotoxicity J Am Coll Cardiol 50 6 2007 528 536 (Pubitemid 47126779)
26. B.T. Hennessy, D.L. Smith, P.T. Ram, Y. Lu, and G.B. Mills Exploiting the PI3K/AKT pathway for cancer drug discovery Nat Rev Drug Discov 4 2005 988 1004
27. J.A. Crowell, V.E. Steele, and J.R. Fay Targetting the AKT protein kinase for cancer chemoprevention Mol Cancer Ther 6 2007 2139 2148 (Pubitemid 47294742)
28. K.C. Arden FoxO: linking new signaling pathways Cell 14 4 2004 416 418 (Pubitemid 38648793)
29. K.M. Nicholson, and N.G. Anderson The protein kinase B/Akt signalling pathway in human malignancy Cell Signal 14 2002 381 395 (Pubitemid 34214843)
30. J.Q. Cheng, C.W. Lindsley, G.Z. Cheng, H. Yang, and S.V. Nicosia The Akt/PKB pathway: molecular target for cancer drug discovery Oncogene 24 2005 7482 7492 (Pubitemid 41637988)
31. I. Vivanco, and C.L. Sawyers The phosphatidylinositol 3-kinase AKT pathway in human cancer Nat Rev Cancer 2 2002 489 501 (Pubitemid 37328931)
32. A. Brunet, A. Bonni, M.J. Zigmond, M.Z. Lin, P. Juo, and L.S. Hu Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor Cell 96 6 1999 857 868 (Pubitemid 29165088)
33. G.J. Kops, N.D. de Ruiter, A.M. De Vries-Smits, D.R. Powell, J.L. Bos, and B.M. Burgering Direct control of the Forkhead transcription factor AFX by protein kinase B Nature 398 6728 1999 630 634 (Pubitemid 29183692)
34. N. Nakamura, S. Ramaswamy, F. Vazquez, S. Signoretti, M. Loda, and W.R. Sellers Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN Mol Cell Biol 20 23 2000 8969 8982 (Pubitemid 32245927)
35. B. Rayet, and C. Gelinas Aberrant rel/nfkb genes and activity in human cancer Oncogene 8 1999 938 947
36. M. Karin, and F.R. Greten NF-kappaB: linking inflammation and immunity to cancer development and progression Nat Rev Immunol 5 2005 749 759 (Pubitemid 41400849)
37. C.Y. Wang, J.C. Cusack Jr., R. Liu, and A.S. Baldwin Jr. Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB Nat Med 5 1999 412 417 (Pubitemid 29180579)
38. M. Barkett, and T.D. Gilmore Control of apoptosis by Rel/NF-kappaB transcription factors Oncogene 18 1999 6910 6924
39. M. Hinz, D. Krappmann, A. Eichten, A. Heder, C. Scheidereit, and M. Strauss NF-κB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition Mol Cell Biol 19 1999 2690 2698 (Pubitemid 29144513)
40. S.D. Westerheide, M.W. Mayo, V. Anest, J.L. Hanson, and A.S. Baldwin Jr. The putative oncoprotein Bcl-3 induces cyclin D1 to stimulate G1 transition Mol Cell Biol 21 2001 8428 8436 (Pubitemid 33108602)
41. B. Singh, L.R. Irving, K. Tai, and A. Lucci Overexpression of COX-2 in celecoxib-resistant breast cancer cell lines J Surg Res 163 2 2010 235 243
42. M. Rinaldi-Carmona, A. Le Duigou, D. Oustric, F. Barth, M. Bouaboula, and P. Carayon Modulation of CB1 cannabinoid receptor functions after a long-term exposure to agonist or inverse agonist in the Chinese hamster ovary cell expression system J Pharmacol Exp Ther 287 3 1998 1038 1047 (Pubitemid 29131618)
43. G. Portella, C. Laezza, P. Laccetti, L. De Petrocellis, V. Di Marzo, and M. Bifulco Inhibitory effects of cannabinoid CB1 receptor stimulation on tumor growth and metastatic spreading: actions on signals involved in angiogenesis and metastasis FASEB J 17 2003 1771 1773
44. C.W. Michalski, F.E. Oti, M. Erkan, D. Sauliunaite, F. Bergmann, and P. Pacher Cannabinoids in pancreatic cancer: correlation with survival and pain Int J Cancer 122 4 2008 742 750
45. T.T. Puck, R. Johnson, P. Webb, H. Cui, J.G. Valdez, and H. Crissman Mutagenesis and repair by low doses of alpha radiation in mammalian cells Proc Natl Acad Sci USA 99 2002 12220 12223
46. M. Domenicali, P. Caraceni, F. Giannone, A.M. Pertosa, A. Principe, and A. Zambruni Cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis Gastroenterology 137 2009 341 349